Basecamp Research raises $140m to design drugs from genetic data of 1m+ unstudied organisms
_rockt · x · 2026-09-23
UK Sovereign AI has invested in Basecamp Research as part of its $140m round. The company has built a database of genetic information from over 1 million unstudied organisms and uses it to design new medicines, including cancer and autoimmune therapies, claiming huge potential to transform drug discovery.
More from Venture
- Indie dev admires years-long SEO sharing but keeps postponing his own growth content over data-leak concerns — yihui_indie · 2026-09-23
- Cross-posting tool Ferryman nears $10,000 MRR with $30-$100/mo tiers and posting straight from Claude and Cursor — KevinNaughtonJr · 2026-09-23
- European humanoid startup Vesoma emerges from stealth, walking its own robot in six months — Jasonio · 2026-09-23
- Tax compliance startup Numeral raises $100M Series C, total funding hits $157M — chetanp · 2026-09-23
- swyx Makes Opus 5.5 the Default for AINews After Head-to-Head Test, Industry Cuts Prices 40-50% — rickasaurus · 2026-09-23
- Ondas acquisitions add sensing, resilient connectivity and GNSS-denied navigation — CeoOndas · 2026-09-23